OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Proactive Therapeutic Drug Monitoring Versus Conventional Management for Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
Nghia Nguyen, Virginia Solitano, Sudheer K. Vuyyuru, et al.
Gastroenterology (2022) Vol. 163, Iss. 4, pp. 937-949.e2
Open Access | Times Cited: 45
Nghia Nguyen, Virginia Solitano, Sudheer K. Vuyyuru, et al.
Gastroenterology (2022) Vol. 163, Iss. 4, pp. 937-949.e2
Open Access | Times Cited: 45
Showing 26-50 of 45 citing articles:
Therapeutic drug monitoring in inflammatory bowel disease: recent developments
Xavier Roblin, Robert D. Little, Nicolas Mathieu, et al.
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 10, pp. 575-586
Closed Access | Times Cited: 1
Xavier Roblin, Robert D. Little, Nicolas Mathieu, et al.
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 10, pp. 575-586
Closed Access | Times Cited: 1
Proactive therapeutic drug monitoring of biologic drugs in patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis: systematic review and meta-analysis
Dena Zeraatkar, Tyler Pitre, Sarah Kirsh, et al.
BMJ Medicine (2024) Vol. 3, Iss. 1, pp. e000998-e000998
Open Access | Times Cited: 1
Dena Zeraatkar, Tyler Pitre, Sarah Kirsh, et al.
BMJ Medicine (2024) Vol. 3, Iss. 1, pp. e000998-e000998
Open Access | Times Cited: 1
The Role of Therapeutic Drug Monitoring in Children
Alexander Nasr, Phillip Minar
Gastroenterology Clinics of North America (2023) Vol. 52, Iss. 3, pp. 549-563
Open Access | Times Cited: 2
Alexander Nasr, Phillip Minar
Gastroenterology Clinics of North America (2023) Vol. 52, Iss. 3, pp. 549-563
Open Access | Times Cited: 2
Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis
Francisco Rodríguez‐Moranta, Federico Argüelles‐Arias, Joaquín Hinojosa del Val, et al.
Gastroenterología y Hepatología (English Edition) (2024) Vol. 47, Iss. 5, pp. 522-552
Open Access
Francisco Rodríguez‐Moranta, Federico Argüelles‐Arias, Joaquín Hinojosa del Val, et al.
Gastroenterología y Hepatología (English Edition) (2024) Vol. 47, Iss. 5, pp. 522-552
Open Access
Therapeutic drug monitoring guidelines in oncology: what do we know and how to move forward? Insights from a systematic review
Xinya Li, Zaiwei Song, Zhan‐Miao Yi, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access
Xinya Li, Zaiwei Song, Zhan‐Miao Yi, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access
Development and validation of a novel therapeutic drug monitoring-based nomogram for prediction of primary endoscopic response to anti-TNF therapy in active Crohn’s disease
Liang Chen, Dengfeng Kang, Leilei Fang, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access
Liang Chen, Dengfeng Kang, Leilei Fang, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access
What are the benefits of therapeutic drug monitoring in the optimization of adalimumab therapy? a systematic review and meta-analysis up to 2022
Yun Li, Cheng Xie, Xiaoliang Ding, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Yun Li, Cheng Xie, Xiaoliang Ding, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Infliximab serum concentrations in luminal Crohn's disease and its relationship with disease activity: A multicentric cross-sectional study
Rodrigo Bremer Nones, Eron Fábio Miranda, Gustavo de Nardi Marçal, et al.
Gastroenterología y Hepatología (English Edition) (2024) Vol. 47, Iss. 7, pp. 711-720
Closed Access
Rodrigo Bremer Nones, Eron Fábio Miranda, Gustavo de Nardi Marçal, et al.
Gastroenterología y Hepatología (English Edition) (2024) Vol. 47, Iss. 7, pp. 711-720
Closed Access
What the Rheumatologist Needs to Know about IBD Treatment
Christopher Ma
Canadian rheumatology today. (2024)
Closed Access
Christopher Ma
Canadian rheumatology today. (2024)
Closed Access
Model-informed precision dosing in inflammatory bowel diseases
Arno R. Bourgonje, Marla C. Dubinsky, Ron J. Keizer, et al.
Trends in Pharmacological Sciences (2024)
Closed Access
Arno R. Bourgonje, Marla C. Dubinsky, Ron J. Keizer, et al.
Trends in Pharmacological Sciences (2024)
Closed Access
Is therapeutic drug monitoring a dancing partner for TNF-α inhibitors in real-world practice? Answers from an updated systematic review and meta-analysis
Yang Hu, Zaiwei Song, Yuan Gao, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 10, pp. 935-948
Open Access
Yang Hu, Zaiwei Song, Yuan Gao, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 10, pp. 935-948
Open Access
Therapeutic drug monitoring for immune mediated inflammatory diseases
Neil Chanchlani, Z.Z.N. Yiu, Lisa K. Stamp, et al.
BMJ Medicine (2024) Vol. 3, Iss. 1, pp. e001130-e001130
Open Access
Neil Chanchlani, Z.Z.N. Yiu, Lisa K. Stamp, et al.
BMJ Medicine (2024) Vol. 3, Iss. 1, pp. e001130-e001130
Open Access
One Concentration Does Not Fit All: It is Time to Personalize the Therapeutic Range of Infliximab in Crohn Disease
Bénédicte Franck, Camille Tron, Marie‐Clémence Verdier, et al.
Therapeutic Drug Monitoring (2024)
Closed Access
Bénédicte Franck, Camille Tron, Marie‐Clémence Verdier, et al.
Therapeutic Drug Monitoring (2024)
Closed Access
Editorial: proactive anti‐TNF drug monitoring in IBD —Ready for prime time?
Xavier Roblin, Stéphane Nancey
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 12, pp. 1453-1454
Open Access | Times Cited: 1
Xavier Roblin, Stéphane Nancey
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 12, pp. 1453-1454
Open Access | Times Cited: 1
The role of therapeutic drug monitoring in the management of inflammatory bowel disease
Devendra Desai, Vikram Dharap
Gastroenterology Hepatology and Endoscopy Practice (2023) Vol. 3, Iss. 3, pp. 72-72
Closed Access | Times Cited: 1
Devendra Desai, Vikram Dharap
Gastroenterology Hepatology and Endoscopy Practice (2023) Vol. 3, Iss. 3, pp. 72-72
Closed Access | Times Cited: 1
Therapeutic drug monitoring of biologics in inflammatory bowel disease
Waqqas Afif, Arti Wongcha-um
Canadian IBD Today (2023)
Open Access
Waqqas Afif, Arti Wongcha-um
Canadian IBD Today (2023)
Open Access
Using a Treat-to-Target Approach to Manage Patients With Inflammatory Bowel Disease.
Cynthia H. Seow
PubMed (2023) Vol. 19, Iss. 7, pp. 415-417
Closed Access
Cynthia H. Seow
PubMed (2023) Vol. 19, Iss. 7, pp. 415-417
Closed Access
Infliximab serum concentrations in luminal Crohn's disease and its relationship with disease activity: A multicentric cross-sectional study
Rodrigo Bremer Nones, Eron Fábio Miranda, Gustavo de Nardi Marçal, et al.
Gastroenterología y Hepatología (2023) Vol. 47, Iss. 7, pp. 711-720
Closed Access
Rodrigo Bremer Nones, Eron Fábio Miranda, Gustavo de Nardi Marçal, et al.
Gastroenterología y Hepatología (2023) Vol. 47, Iss. 7, pp. 711-720
Closed Access
